Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemia

被引：0

作者：

Shanshan Guo ^{[1
]}

Ekaterina Bourova-Flin ^{[2
]}

Sophie Rousseaux ^{[3
]}

Florent Chuffart ^{[2
]}

Lijun Peng ^{[3
]}

Duohui Jing ^{[2
]}

Jian-Qing Mi ^{[3
]}

Saadi Khochbin ^{[2
]}

Jin Wang ^{[3
]}

机构：

[1] Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai

[2] Univ. Grenoble Alpes,undefined

[3] CNRS UMR 5309 and INSERM U1209,undefined

[4] Institute for Advanced Biosciences,undefined

[5] Pôle Franco-Chinois de Recherche en Sciences du Vivant Et Génomique,undefined

来源：

Journal of Translational Medicine | / 23卷 / 1期

关键词：

T-cell acute lymphoblastic leukemia; Mitochondrial activity; activation; Lipid accumulation; Drug resistance;

D O I：

10.1186/s12967-025-06423-4

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia
Liu, Jizhong
Masurekar, Ashish
Johnson, Suzanne
Chakraborty, Sohini
Griffiths, John
Smith, Duncan
Alexander, Seema
Dempsey, Clare
Parker, Catriona
Harrison, Stephanie
Li, Yaoyong
Miller, Crispin
Di, Yujun
Ghosh, Zhumur
Krishnan, Shekhar
Saha, Vaskar
ONCOTARGET, 2015, 6 (40) : 43048 - 43064
[42] MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
van der Zwet, Jordy C. G.
Buijs-Gladdines, Jessica G. C. A. M.
Cordo', Valentina
Debets, Donna O.
Smits, Willem K.
Chen, Zhongli
Dylus, Jelle
Zaman, Guido J. R.
Altelaar, Maarten
Oshima, Koichi
Bornhauser, Beat
Bourquin, Jean-Pierre
Cools, Jan
Ferrando, Adolfo A.
Vormoor, Josef
Pieters, Rob
Vormoor, Britta
Meijerink, Jules P. P.
LEUKEMIA, 2021, 35 (12) : 3394 - 3405
[43] Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Genesca, Eulalia
Gonzalez-Gil, Celia
CANCERS, 2022, 14 (10)
[44] CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study
Qian, Jie-Jing
Hu, Xiaoxia
Wang, Ying
Zhang, Yi
Du, Juan
Yang, Min
Tong, Hongyan
Qian, Wen-Bin
Wei, Juying
Yu, Wenjun
Lou, Yin-Jun
Mao, Liping
Meng, Hai Tao
You, Liang-Shun
Wang, Libing
Li, Xia
Huang, Xin
Cao, Li-Hong
Zhao, Jian-Zhi
Yan, Xiao Yan
Chen, Yu-Bao
Chen, Yu
Zhang, Su-Jiang
Jin, Jie
Hu, Jiong
Zhu, Hong-Hu
CANCER MEDICINE, 2020, 9 (15): : 5327 - 5334
[45] Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia
Styczynski, J
Wysocki, M
HAEMATOLOGIA, 2002, 32 (04) : 313 - 325
[46] Nelarabine for the Treatment of Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
DeAngelo, Daniel J.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (05) : 1121 - +
[47] Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma
Mansour, Marc R.
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (02) : 133 - 136
[48] MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies
Li, Qilong
Pan, Sa
Xie, Ting
Liu, Hudan
BLOOD SCIENCE, 2021, 3 (03): : 65 - 70
[49] Animal models of T-cell acute lymphoblastic leukemia: mimicking the human disease
You Qin
Su Hexiu
Wang Jingchao
Jiang Jue
Qing Guoliang
Liu Hudan
生物组学研究杂志（英文）, 2018, 1 (01)
[50] T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development
Thomas, Xavier
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (01) : 37 - 52

← 1 2 3 4 5 →